(Q44221482)

1 December 2017

IL-32 aggravates synovial inflammation and bone destruction and increases synovial natural killer cells in experimental arthritis models (English)

1 reference

1 December 2017

Young-Eun Park

1

1 reference

1 December 2017

Geun-Tae Kim

2

1 reference

1 December 2017

Seung-Geun Lee

3

1 reference

1 December 2017

Seong-Hu Park

4

1 reference

1 December 2017

Seung-Hoon Baek

5

1 reference

1 December 2017

Sung-Il Kim

6

1 reference

1 December 2017

Ju-In Kim

7

1 reference

1 December 2017

Hua-Shu Jin

8

1 reference

1 December 2017

19 April 2012

1 reference

Rheumatology International

1 December 2017

1 reference

1 December 2017

33

1 reference

1 December 2017

3

1 reference

1 December 2017

671-679

1 reference

https://scigraph.springernature.com/pub.10.1007/s00296-012-2385-5

1 December 2017

0 references

cites work

Evolving concepts of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Prospective new biological therapies for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

IL-32, a proinflammatory cytokine in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

IL-32, a novel cytokine with a possible role in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Natural killer cells in human autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Circulating natural killer cells in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Rheumatoid arthritis and interleukin-32.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Interleukin-32 promotes osteoclast differentiation but not osteoclast activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Rheumatoid arthritis. Pathophysiology and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Human CD4+ T cell differentiation and effector function: implications for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Functional diversity of helper T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

The expanding universe of T-cell subsets: Th1, Th2 and more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Interleukin 18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Regulation of interferon-gamma production by IL-12 and IL-18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Defective NK cell activity and Th1 response in IL-18-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

A proinflammatory role for IL-18 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Natural killer cell receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

The biology of human natural killer-cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

The instructive role of innate immunity in the acquired immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Regulation of adaptive immunity by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

NK cell functions restrain T cell responses during viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Dendritic and natural killer cells cooperate in the control/switch of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Protective role of NK1.1+ cells in experimental Staphylococcus aureus arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

The many roles of chemokines and chemokine receptors in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Chemokines and chemokine receptors in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2385-5

Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production

21 January 2018

1 reference

12 December 2020

Biology and clinical relevance of human natural killer cells

1 reference

12 December 2020

Interleukin-32: a cytokine and inducer of TNFalpha

1 reference

12 December 2020

Targeting the T cell receptor in rheumatoid arthritis

1 reference

12 December 2020

IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses

1 reference

12 December 2020

Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes

1 reference

12 December 2020

A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus

1 reference

12 December 2020

10.1007/S00296-012-2385-5

Identifiers

DOI

1 reference

1 December 2017

1 reference